Non-invasive prenatal examination kits
Non-invasive determination of the gender and Rh factor of the child - This is a genetic laboratory diagnostic method that allows you to determine the result from the mother’s blood in early pregnancy (from the 10th week) with an accuracy of 99%. The results of the study are based on the detection of fetal DNA in the blood of a pregnant woman.
Kits are based on the principle of "real-time PCR." In the work, an approach is used that allowed to increase the sensitivity of test systems to identify single fetal DNA molecules in the blood of a pregnant woman. For this, ultra-short probes, unique primers and high-performance polymerases are used.
Diagnostic kits for identification of fetal DNA by maternal blood produced by InBio have Registration Certificate No. ФСР 2010/09565 dated 02/18/2020 issued by ROSZRAVNADZOR.
Test SRY - a test system for non-invasively determining the sex of the fetus from the 10th (embryological) week of pregnancy by the blood of a pregnant woman is of particular importance for families at risk of developing a sex-linked disease.
Test RHD - a test system for non-invasive detection of the gene of the Rh factor of the fetus from the 10th (embryological) week of pregnancy.
Get a commercial offer
Set for identification of the SRY gene of the fetus in the blood of the mother "DNA-sex of the child" number of determinations: 30
Set for identification of the SRY gene of the fetus in the blood of the mother "DNA-gender of the child plus" number of determinations: 50/100
Set for identification of the Rh factor gene (RHD) of the fetus in the mother’s blood “DNA-Rh baby” number of determinations: 30
Set for identification of the Rh factor gene (RHD) of the fetus in the mother’s blood “DNA Rh plus” number of determinations: 50/100
Rhesus factor incompatibility between maternal and fetal blood is one of the most common causes of hemolytic disease of the fetus and newborn. This pathology has both medical, social, and economic importance.
Rhesus incompatibility is one of the most common causes of hemolytic disease in newborns. However, it is possible to overcome undesirable reactions during pregnancy and childbirth by using anti-Rh immunoglobulin.
The possibility of prenatal diagnosis of the Rh factor of the fetus by blood of a pregnant Rh-negative woman
In Russia, the percentage of Rh sensitized women reaches 1.2%. In developed countries, the number of women with Rh sensitization is 0.1–0.2%. Such a low percentage achieved
The importance of prenatal diagnosis of the Rh factor of the fetus to improve the quality of medical care for pregnant women with Rh-negative blood in modern environmental conditions
The discovery of the rhesus (Rh) blood system is closely related to the first description of hemolytic disease of the newborn (GBN). The cause of this disease
Evaluation of the medical and economic effectiveness of prenatal non-invasive screening of the fetus Rh factor
Rhesus factor incompatibility between the fetus and mother can be the main cause of the Rh conflict and hemolytic disease of the fetus and newborns. The successes of developed countries in recent decades in solving the problem of hemolytic